MAR
12
MAI
11
Recently established in Cambridge (within the prestigious Silicon Fen), BIOTEM actively pursues its international development and joins OneNucleus in April 2011.
Based in London and Cambridge, this organisation federates a network over 500 members at the heart of the first European cluster dedicated to life sciences.
SEP
10
Founded in 1980, BIOTEM is the first French CMO to have proposed the production of customised monoclonal antibodies.
To mark the 30th anniversary of the company, we would like to thank you all our partners and customers for their trust and contribution to BIOTEM's success.
Today, BIOTEM actively continues its development and confirms its position as a leader in the field of monoclonal antibodies.
* Contrat Manufacturing Organisation
JUN
09
MAI
09
NOV
08
AOû
08
DéC
07
AVR
07
This exclusive method allows the fast development of hybridomas in less than a month (immunisation, fusion and screening included).
OCT
06
BIOTEM complies with the ISO 9001:2000 quality standards
MAI
06











